Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Figure out how to Arrange a Fair Settlement with the Assistance of a Fender bender Legal counselor - 2Without evidence, CDC changes messaging on vaccines and autism
- 3NASA to bring astronauts home from space station early due to a medical issue
- 4Pick Your Favored method of transportation
- 5Instructions to Pick the Best Course for Your Next Waterway Voyage: Objections, Views, and Social Encounters
- The Job of Attorneys: It is Important to Comprehend When Legitimate Help
- Barry Manilow reveals lung cancer diagnosis and plans to undergo surgery: 'It's pure luck' it was 'found so early'
- NASA shares first photos of Earth taken by Artemis II
- Vote In favor of Your Favored Distributed computing Administration
- Share your pick for the tree that you love for its novel magnificence!
- 5 Cell phones of the Year
- From Loner to Force to be reckoned with: Individual Accounts of Change
- Best Amusement Park in Europe: Where Do You Very much want to Visit?
- Vote in favor of the Top Vegetable for Senior
